Sotrovimab

MedChem Express

Sotrovimab

10

Research Use Only

Monoclonal

98.00

Sotrovimab (VIR 7831) is a human IgG1kappa pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease [1] [2] .

-80°C

12352203